As Rowse expands from skincare to make-up, Wallpaper* speaks exclusively with co-founders Nuria Val and Gabriela Salord about ...

As Pfizer navigates these challenges, it faces rising competition from agile biotech firms wielding AI, gene editing, and mRNA technologies. By 2030, these innovators could surpass Pfizer’s drug ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

The writing is on the wall at Mural Oncology. Responding to clinical data, the biotech is laying off 90% of its employees and stopping clinical development of its lead program to hunker down and ...

Earlier this week, the congressionally-mandated National Security Commission on Emerging Biotechnology released its major report, titled “Charting the Future of Biotechnology.” The bipartisan ...

A US congressional commission has urged lawmakers to take action to counter China’s “frightening” ascent in biotechnology, flagging Chinese firms including WuXi AppTec and BioMap ...

China is moving fast to dominate biotechnology, and the U.S. risks falling behind permanently unless it takes action over the next three years, a congressional commission said. Congress should ...

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...

Biotechnology offers a scalable alternative, but realizing its full potential requires commitment from governments and space agencies. By harnessing biological processes such as microbial and ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention. The industry has recovered from a challenging 2024 and is ...

Some hoped the biotech's stock could soar due to another company acquiring it, but that now seems unlikely. The drugmaker is a fairly attractive long-term option regardless of Wall Street's price ...

China has captured production of portions of the global biotechnology supply chain to accomplish President Xi Jinping’s goal to “develop effective deterrent against attempts by other countries ...